Validity, reliability and optimisation of the TOPICOP questionnaire for oral lichen planus

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing, 2013.
   Google Scholar
• Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515–528.
   PubMed Web of Science ®Google Scholar
• Curtis GC, Magee WJ, Eaton WW, et al. Specific fears and phobias. Epidemiology and classification. Br J Psychiatry. 1998;173:212–217.
   PubMed Web of Science ®Google Scholar
• Marks R. Pharmaphilia and pharmaphobia. Clin Dermatol. 2001;19(1):69–71.
   PubMed Web of Science ®Google Scholar
• Rao VU, Apter AJ. Steroid phobia and adherence–problems, solutions, impact on benefit/risk profile. Immunol Allergy Clin North Am. 2005;25(3):581–595.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Tuft L. Steroid-phobia” in asthma management. Ann Allergy. 1979;42(3):152–159.
   PubMedGoogle Scholar
• Thongprasom K, Carrozzo M, Furness S, et al. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2011;6:CD001168.
   Google Scholar
• González-Moles MA, Scully C. Vesiculo-erosive oral mucosal disease–management with topical corticosteroids: (1) Fundamental principles and specific agents available. J Dent Res. 2005;84(4):294–301.
   PubMed Web of Science ®Google Scholar
• Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8(10):e76493.
   PubMed Web of Science ®Google Scholar
• Mueller SM, Itin P, Vogt DR, et al. Assessment of “corticophobia” as an indicator of non-adherence to topical corticosteroids: a pilot study. J Dermatolog Treat. 2017;28(2):104–111.
   PubMed Web of Science ®Google Scholar
• Stalder J, Aubert H, Anthoine E, et al. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Allergy. 2017;72(11):1713–1719.
   PubMed Web of Science ®Google Scholar
• Li AW, Yin ES, Antaya RJ. Topical corticosteroid phobia in atopic dermatitis: a systematic review. JAMA Dermatol. 2017;153(10):1036–1042.
   PubMed Web of Science ®Google Scholar
• Arduino PG. Oral complications of dermatologic disorders. Atlas Oral Maxillofac Surg Clin North Am. 2017;25(2):221–228.
   PubMedGoogle Scholar
• Vilar Villanueva M, Gándara Vila P, Blanco Aguilera E, et al. Psychological disorders and quality of life in oral lichen planus patients and a control group. Oral Dis. 2019;25(6):1645–1651.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Moles MA, Scully C. HPA-suppressive effects of aqueous clobetasol propionate in the treatment of patients with oral lichen planus. J Eur Acad Dermatol Venereol. 2009;24:1055–1059.
   Web of Science ®Google Scholar
• Wiriyakijja P, Fedele S, Porter SR, et al. Patient-reported outcome measures in oral lichen planus: a comprehensive review of the literature with focus on psychometric properties and interpretability. J Oral Pathol Med. 2018;47(3):228–239.
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol. 1978;46:518–539.
   PubMedGoogle Scholar
• Thongprasom K, Luangjarmekorn L, Sererat T, et al. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med. 1992;21(10):456–458.
   PubMed Web of Science ®Google Scholar
• González-García A, Diniz-Freitas M, Gándara-Vila P, et al. Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: efficacy and risk of fungal over-infection. Oral Dis. 2006;12(6):559–565.
   PubMed Web of Science ®Google Scholar
• Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19(4):539–549.
   PubMed Web of Science ®Google Scholar
• Terwee CB, Mokkink LB, Knol DL, et al. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651–657.
   PubMed Web of Science ®Google Scholar
• Fletcher AJ, Marchildon GP. Using the delphi method for qualitative, participatory action research in health leadership. Int J Qual Methods. 2014;13(1):1–18.
   Google Scholar
• Miguéns-Vila R, Ledesma-Ludi Y, Rodríguez-Lozano F, et al. Disparities between English and Spanish in readability of online endodontic information for laypeople. J Am Dent Assoc. 2018;149(11):960–966.
   PubMed Web of Science ®Google Scholar
• Wild D, Eremenco S, Mear I, et al. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Value Health. 2009;12:430–440.
   PubMed Web of Science ®Google Scholar
• Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011;86(4):304–314.
   PubMed Web of Science ®Google Scholar
• Ní Ríordáin R, Shirlaw P, Alajbeg I, et al. World Workshop on Oral Medicine VI: patient-reported outcome measures and oral mucosal disease: current status and future direction. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120:160.e11.
   Web of Science ®Google Scholar
• DeVellis RF. Scale development; theory and applications. Thousand Oaks (CA): Sage Publications, 2003.
   Google Scholar